CN Patent

CN103153993B — 治疗癌症和免疫与自身免疫疾病的细胞程序死亡诱导药剂

Assigned to Aibo Wei Ireland Ltd · Expires 2016-06-01 · 10y expired

What this patent protects

公开的是抑制抗凋亡Bcl-2蛋白的活性的化合物、含有该化合物的组合物和治疗患病期间抗凋亡Bcl-2蛋白被表达的疾病的方法。 ？

USPTO Abstract

公开的是抑制抗凋亡Bcl-2蛋白的活性的化合物、含有该化合物的组合物和治疗患病期间抗凋亡Bcl-2蛋白被表达的疾病的方法。 ？

Drugs covered by this patent

Patent Metadata

Patent number
CN103153993B
Jurisdiction
CN
Classification
—
Expires
2016-06-01
Drug substance claim
No
Drug product claim
No
Assignee
Aibo Wei Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.